483
Sarah E. Zauber, M.D.FDA 483 - Sarah E. Zauber, M.D. - September 16, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Sarah E. Zauber, M.D. in Indianapolis, IN, a Clinical Investigator, revealed a significant deficiency in the conduct of an investigation. The firm failed to adhere to its investigational plan by not reconsenting study subjects with updated informed consent forms, despite an IRB approval for an amendment that increased potential risks. This indicates a serious lapse in protecting study participants and following established protocols.
Open in Dashboard
ID · a9e41af7-4db8-47e7-a4bc-ccd952618f37